Key Drivers
- Margin compression
- Cash flow
- Rich valuation
AIAI Summary
WAT is no longer a simple quality-compounding story: the sharp Q1 2026 gross-margin drop, negative operating income, and near-breakeven FCF mean investors now need to see quick margin recovery and cash conversion before paying up for its innovation pipeline and recovery potential.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin compression
- •Cash flow
- •Rich valuation
Waters posted strong full-year profitability and cash generation, but the latest quarter showed sharp margin and cash-flow deterioration, making execution risk and a rich valuation the main concerns.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •Support holding
- •Resistance cap
WAT has improved over the last month with higher lows and support holding above $368-$370, but it remains capped near $379-$380 resistance, so a breakout or pullback is the next likely move.
Dropped from the 2026-06-03 area into the 2026-06-18 low before rebounding
Sentiment & News
Key News Insights:
- •Product Expansion
- •AI Partnership
- •Earnings Checkpoint
Waters is accelerating growth through new battery and bioseparation product launches plus an AI immune-mapping partnership, with the upcoming Q2 2026 earnings call set to gauge execution and outlook.
The news points to a positive innovation pipeline and broader market reach, with the August earnings call likely the next key catalyst for investor sentiment
Similar Companies in Healthcare
Other companies in the same sector with AI ratings